Petković-Dabić, J.; Binić, I.; Carić, B.; Božić, L.; Umičević-Šipka, S.; Bednarčuk, N.; Dabić, S.; Šitum, M.; Popović-Pejičić, S.; Stojiljković, M.P.;
et al. Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial. Biomolecules 2025, 15, 46.
https://doi.org/10.3390/biom15010046
AMA Style
Petković-Dabić J, Binić I, Carić B, Božić L, Umičević-Šipka S, Bednarčuk N, Dabić S, Šitum M, Popović-Pejičić S, Stojiljković MP,
et al. Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial. Biomolecules. 2025; 15(1):46.
https://doi.org/10.3390/biom15010046
Chicago/Turabian Style
Petković-Dabić, Jelena, Ivana Binić, Bojana Carić, Ljiljana Božić, Sanja Umičević-Šipka, Nataša Bednarčuk, Saša Dabić, Mirna Šitum, Snježana Popović-Pejičić, Miloš P. Stojiljković,
and et al. 2025. "Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial" Biomolecules 15, no. 1: 46.
https://doi.org/10.3390/biom15010046
APA Style
Petković-Dabić, J., Binić, I., Carić, B., Božić, L., Umičević-Šipka, S., Bednarčuk, N., Dabić, S., Šitum, M., Popović-Pejičić, S., Stojiljković, M. P., & Škrbić, R.
(2025). Effects of Semaglutide Treatment on Psoriatic Lesions in Obese Patients with Type 2 Diabetes Mellitus: An Open-Label, Randomized Clinical Trial. Biomolecules, 15(1), 46.
https://doi.org/10.3390/biom15010046